Guardant Health Inc.

06/18/2026 | Press release | Distributed by Public on 06/18/2026 14:12

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.

The annual meeting of stockholders (the "Annual Meeting") of Guardant Health, Inc. (the "Company") was held on June 17, 2026.

All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 28, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors by the following vote:

Name of Nominee Votes For Votes Withheld Broker Non-Votes

Ian Clark

70,526,891 37,916,548 7,714,711

Manuel Hidalgo Medina

81,925,123 26,518,316 7,714,711

Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote:

Votes For

Votes Against

Abstentions

115,899,030 15,250 243,870

Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, was not approved by the following vote:

Votes For

Votes Against

Abstentions

Broker Non-Votes

98,236,639 9,905,190 301,610 7,714,711

Proposal 4 in the Proxy Statement, a proposal to determine, on an advisory (non-binding) basis, the frequency of future stockholder advisory votes regarding the compensation of the Company's named executive officers, was determined as follows:

Votes Cast for One Year

Votes Cast For Two Years

Votes Cast for Three Years

Abstentions

Broker Non-Votes

107,997,996 14,303 265,413 165,727 7,714,711
Guardant Health Inc. published this content on June 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 18, 2026 at 20:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]